Skip to main content

Investigation On Behalf Of Alpharma Inc Investors By A Law Firm Concerning The Proposed Alpharma, Inc. Acquisition By King Pharmaceuticals, Inc. Announced

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

According to a press release a law firm is currently on behalf of Alpharma, Inc. (NYSE:ALO) shareholders investigating potential Alpharma, Inc. (NYSE:ALO) shareholder claims arising from the proposed acquisition of Alpharma, Inc. by King Pharmaceuticals, Inc. According to the press release on November 24, 2008 King Pharmaceuticals Inc. and Alpharma, Inc. announced the signing of a de...



You must register (for free) or login to view the entire investigation.